Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jul 1;137(1):13-14.
doi: 10.1097/ALN.0000000000004241.

Hypoxia and Hypercoagulability in COVID-19: Chicken or the Egg?

Affiliations
Editorial

Hypoxia and Hypercoagulability in COVID-19: Chicken or the Egg?

David J Douin et al. Anesthesiology. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing Interests

Dr. Fernandez-Bustamante has received funding for research not related with the topic of this article from the United States Department of Defense (Washington, D.C.) and the Merck Sharp & Dohme Corp. (Kenilworth, New Jersey) investigator-initiated studies program. The authors are not supported by, nor maintain any financial interest in, any commercial activity that may be associated with the topic of this article.

Comment on

Similar articles

References

    1. Schultz MJ, Haitsma JJ, Zhang H, Slutsky AS: Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia: A review. Crit Care Med 2006; 34:871–7 - PubMed
    1. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B: Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 2020; 395:1054–62 - PMC - PubMed
    1. Al-Samkari H, Karp Leaf RS, Dzik WH, Carlson JCT, Fogerty AE, Waheed A, Goodarzi K, Bendapudi PK, Bornikova L, Gupta S, Leaf DE, Kuter DJ, Rosovsky RP: COVID-19 and coagulation: Bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood 2020; 136:489–500 - PMC - PubMed
    1. Corey KM, Olson LB, Naqvi IA, Morrison SA, Davis C, Nimjee SM, Que LG, Bachelder RE, Kraft BD, Chen L, Nair SK, Levy JH, Sullenger BA: Suppression of fibrinolysis and hypercoagulability, severity of hypoxemia, and mortality in COVID-19 patients: A retrospective cohort study. Anesthesiology 2022; 137:67–78 - PMC - PubMed
    1. Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, Li WW, Li VW, Mentzer SJ, Jonigk D: Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. N Engl J Med 2020; 383:120–8 - PMC - PubMed